U.S., Aug. 20 -- An application to own the trademark for 'ANKESDRY' has been filed on Feb. 06, 2025.
Owner(s):
Vertex Pharmaceuticals Incorporated; 50 Northern Avenue, , MASSACHUSETTS
Goods and/or Services:
For: Pharmaceuticals and medicines for the treatment of cystic fibrosis, pain, sickle cell disease, beta thalassemia, muscular dystrophy, diabetes, respiratory diseases, liver disease, kidney disease, alpha-1 antitrypsin deficiency and APOL1-mediated diseases
Class(es): 005, 006, 018, 044, 046, 051, 052
Mark Drawing Type: 4 - STANDARD CHARACTER MARK
https://eog-tmng.uspto.gov/#/issueDate=2025-08-19&serialNumber=99031093
Disclaimer: Curated by HT Syndication....